Huang Honglan, Jia Chengxuan, Chen Xinying, Zhang Li, Jiang Yang, Meng Xianglong, Liu Xianjun
College of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Department of Gastrointestinal Colorectal and Anal Surgery, The China-Japan Union Hospital of Jilin University, Changchun, China.
Front Nutr. 2024 Feb 28;11:1308384. doi: 10.3389/fnut.2024.1308384. eCollection 2024.
Quinoa is a highly nutritious whole-grain crop with unique values as both a food and medicinal supplement. At present, the roles played by the intestinal microflora in human health are gaining considerable attention from the research community, and studies to date have shown that the occurrence of a range of diseases may be associated with an imbalance of the intestinal flora. The bioactive compounds of quinoa affect the production of SCFAs and the adjustment of intestinal pH. In this article, we review the mechanisms underlying the effects of different quinoa constituents on the intestinal flora, the effects of these constituents on the intestinal flora of different hosts, and progress in research on the therapeutic properties of quinoa constituents, to provide a better understanding of quinoa in terms its dual medicinal and nutritional properties. We hope this review will provide a useful reference for approaches that seek to enhance the composition and activities of the intestinal flora.
藜麦是一种营养丰富的全谷物作物,作为食品和药用补充剂都具有独特价值。目前,肠道微生物群在人类健康中所起的作用正受到研究界的广泛关注,迄今为止的研究表明,一系列疾病的发生可能与肠道菌群失衡有关。藜麦的生物活性化合物会影响短链脂肪酸的产生以及肠道pH值的调节。在本文中,我们综述了藜麦不同成分对肠道菌群产生影响的潜在机制、这些成分对不同宿主肠道菌群的影响以及藜麦成分治疗特性的研究进展,以便从其药用和营养双重特性方面更好地了解藜麦。我们希望这篇综述能为旨在改善肠道菌群组成和活性的方法提供有用的参考。